Floriani Francisco MD is categorized under Internal Medicine Doctors in Bellflower, CA and active since 2011.
Floriani Francisco MD was established in 2011, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Francisco Floriani at the company’s single location by writing to 9400 Rosecrans Avenue, Bellflower, California CA 90706 or by phoning (562) 803-1311. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Floriani Francisco MD |
| Contact Person: | Francisco Floriani |
| Address: | 9400 Rosecrans Avenue, Bellflower, California 90706 |
| Phone Number: | (562) 803-1311 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Floriani Francisco MD was started in 2011 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Francisco Floriani for inquiries that concern Floriani Francisco MD by calling the company number (562) 803-1311, as your correspondence is most welcome. Additionally, the physical location of the single location of Floriani Francisco MD can be found at the coordinates 33.90403,-118.13232 as well as the street address 9400 Rosecrans Avenue in Bellflower, California 90706.
For its online presence, you may visit Floriani Francisco MD’s website at and engage with its social media outlets through on Twitter and on Facebook.